Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy, covering 2017-10-13 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial [Phase 1, Phase 2]